Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial
Qu, Jinglei, He, Xin, Luo, Ying, Yu, Ping, Chen, Ying, Liu, Jing, Wang, Xin, Wang, Chang, Liang, Tingting, Bai, Yuxian, Han, Yu, Man, Li, Leng, Chuanchun, Zhou, Caiyun, He, Lijie, Wang, Xin, Liu, Yunpeng, Qu, Xiujuan
Published in Frontiers in oncology (24.04.2023)
Published in Frontiers in oncology (24.04.2023)
Get full text
Journal Article